BACKGROUND: The trefoil peptides are major secretory products of mucus cells of the gastrointestinal tract and show increased expression after inflammatory or ulcerative damage. Recombinant human TFF2 (spasmolytic polypeptide) has been shown to be cytoprotective, and enhances repair in models of gastric injury. AIMS: To test the healing effects of recombinant human (h)TFF2 in a rat model of chronic colitis. METHODS: Colitis was induced by intracolonic administration of dinitrobenzene sulphonic acid in ethanol. Mucosal repair was quantified macroscopically, microscopically by image analysis of tissue histology, and by measuring myeloperoxidase activity. RESULTS: Initial validation studies showed that maximal injury and inflammation occurred at the end of the first week after colitis induction (active phase), and that spontaneous healing was complete by eight weeks. Once daily intrarectal application of hTFF2 (2.5 mg/kg; approximately 0.5 mg/rat) for five days after maximal damage had been sustained, reduced both microscopic and macroscopic injury by 80% and inflammatory index by 50% compared with vehicle controls. In addition, endogenous concentrations of rat TFF2 and TFF3 (intestinal trefoil factor) were increased in the active phase of colitis and were reduced to basal levels by hTFF2 treatment. CONCLUSIONS: This study has shown that hTFF2 enhances the rate of colonic epithelial repair, and reduces local inflammation in a rat model of colitis, and suggests that luminal application of trefoil peptides may have therapeutic potential in the treatment of inflammatory bowel disease.
BACKGROUND: The trefoil peptides are major secretory products of mucus cells of the gastrointestinal tract and show increased expression after inflammatory or ulcerative damage. Recombinant humanTFF2 (spasmolytic polypeptide) has been shown to be cytoprotective, and enhances repair in models of gastric injury. AIMS: To test the healing effects of recombinant human (h)TFF2 in a rat model of chronic colitis. METHODS:Colitis was induced by intracolonic administration of dinitrobenzene sulphonic acid in ethanol. Mucosal repair was quantified macroscopically, microscopically by image analysis of tissue histology, and by measuring myeloperoxidase activity. RESULTS: Initial validation studies showed that maximal injury and inflammation occurred at the end of the first week after colitis induction (active phase), and that spontaneous healing was complete by eight weeks. Once daily intrarectal application of hTFF2 (2.5 mg/kg; approximately 0.5 mg/rat) for five days after maximal damage had been sustained, reduced both microscopic and macroscopic injury by 80% and inflammatory index by 50% compared with vehicle controls. In addition, endogenous concentrations of ratTFF2 and TFF3 (intestinal trefoil factor) were increased in the active phase of colitis and were reduced to basal levels by hTFF2 treatment. CONCLUSIONS: This study has shown that hTFF2 enhances the rate of colonic epithelial repair, and reduces local inflammation in a rat model of colitis, and suggests that luminal application of trefoil peptides may have therapeutic potential in the treatment of inflammatory bowel disease.
Authors: M C Rio; J P Bellocq; J Y Daniel; C Tomasetto; R Lathe; M P Chenard; A Batzenschlager; P Chambon Journal: Science Date: 1988-08-05 Impact factor: 47.728
Authors: N A Wright; R Poulsom; G W Stamp; P A Hall; R E Jeffery; J M Longcroft; M C Rio; C Tomasetto; P Chambon Journal: J Pathol Date: 1990-12 Impact factor: 7.996
Authors: M C Rio; M P Chenard; C Wolf; L Marcellin; C Tomasetto; R Lathe; J P Bellocq; P Chambon Journal: Gastroenterology Date: 1991-02 Impact factor: 22.682
Authors: Mireille K Makkink; Nicole M J Schwerbrock; Michael Mähler; Jos A Boshuizen; Ingrid B Renes; Markus Cornberg; Hans J Hedrich; Alexandra W C Einerhand; Hans A Büller; Siegfried Wagner; Marie-Luise Enss; Jan Dekker Journal: Dig Dis Sci Date: 2002-10 Impact factor: 3.199
Authors: Daniela Vieten; Anthony Corfield; Daniel Carroll; Pramila Ramani; Richard Spicer Journal: Pediatr Surg Int Date: 2004-12-02 Impact factor: 1.827
Authors: M B Loncar; E-d Al-azzeh; P S M Sommer; M Marinovic; K Schmehl; M Kruschewski; N Blin; R Stohwasser; P Gött; T Kayademir Journal: Gut Date: 2003-09 Impact factor: 23.059